DEERFIELD, Ill.--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) announced today that the company has reached an agreement with the Securities and Exchange Commission (SEC) to fully resolve an investigation into forward-looking financial goals and related disclosures by Walgreen Co. (Walgreens). The

DEERFIELD, Ill. & HANGZHOU, China--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) and Alibaba Group Holding Ltd. (“Alibaba”) (NYSE: BABA) today announced the launch of a Boots flagship store on Tmall Global, Alibaba’s B2C platform for international brands and retailers, to introduce a number of iconic

DEERFIELD, Ill.--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) will release its fourth quarter and fiscal 2018 earnings results at 7 a.m. Eastern time Thursday, October 11, 2018 followed by a one-hour conference call with Walgreens Boots Alliance management beginning at 8:30 a.m. Eastern time.

DEERFIELD, Ill.--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that, following receipt of regulatory approvals, it has completed the previously announced agreement to acquire a 40 percent minority stake in Sinopharm Holding GuoDa Drugstores Co., Ltd. (“GuoDa”), a leading retail

DEERFIELD, Ill.--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced financial results for the third quarter of fiscal 2018, which ended 31 May 2018.

DEERFIELD, Ill.--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that its board of directors has authorized a share repurchase program for up to $10 billion of the company’s shares. The program has no specified expiration date.

DEERFIELD, Ill.--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that, following receipt of regulatory approvals, it has completed the previously announced sale of a 30 percent interest in Guangzhou Pharmaceuticals Corporation to its joint venture partner Guangzhou Baiyunshan

DEERFIELD, Ill.--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) will release its fiscal 2018 third quarter earnings results at 7 a.m. Eastern time Thursday, 28 June 2018, followed by a one-hour conference call with Walgreens Boots Alliance management beginning at 8:30 a.m. Eastern time.

DEERFIELD, Ill.--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) announced today it will hold a Sell-Side Analyst Event on Tuesday, 22 May in New York City. The event will be hosted by Walgreens Boots Alliance Executive Vice Chairman and CEO Stefano Pessina, Co-Chief Operating Officer Alex Gourlay and

DEERFIELD, Ill.--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that its board of directors has declared a regular quarterly dividend of 40 cents per share, an increase of 6.7 percent over the year-ago period. The dividend is payable 12 June 2018 to stockholders of record as of 18 May

DEERFIELD, Ill.--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced financial results for the second quarter of fiscal 2018, which ended 28 February 2018.

DEERFIELD, Ill.--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced the appointment of James Kehoe, recently chief financial officer and board director of Takeda Pharmaceutical Company Limited, as the company’s executive vice president and global chief financial officer, effective June 1

DEERFIELD, Ill.--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) will release its fiscal 2018 second quarter earnings results at 7 a.m. Eastern time Wednesday, 28 March 2018, followed by a one-hour conference call with Walgreens Boots Alliance management beginning at 8:30 a.m. Eastern time.